In November 2025, Abbott agreed to acquire Exact Sciences for approximately $21 billion. Madison, Wisconsin–based Exact ...

HeartBeam (Nasdaq:BEAT) announced today that it entered into a strategic collaboration with the Icahn School of Medicine at Mount Sinai.

The Medtronic Symplicity Spyral system ablates nerves in the vessel wall to treat hypertension. [Illustration courtesy of Medtronic] Medtronic (NYSE: MDT) + today shared new, long-term data ...

Medtronic (NYSE: MDT) announced today that it entered into a definitive agreement to acquire Scientia Vascular in a $550 million deal.

OncoPatch announced today that it received FDA 510(k) for its Oncopatch Surface brachytherapy system for treating localized tumors.

Verily will integrate data from Samsung’s Galaxy Watch, enabling research sponsors to run real-world studies with re-contactable participants.

Stereotaxis (NYSE:STXS) today reported its fourth-quarter and full-year financial results ahead of expected growth in 2026.

View streamlines imaging analysis and visualization by using a suite of AI-enabled tools intended to aid clinical decision making.

Stryker (NYSE: SYK) announced today that it launched its new SmartHospital platform aimed at transforming care delivery.

Olympus announced today that it appointed Denise Lane to the role of chief officer of inclusion (COI), effective April 1, ...

Pulse Biosciences (Nasdaq:PLSE) today announced clinical findings demonstrating the durability of its nPulse Vybrance system.

ReVision Implant announced today that it received FDA breakthrough device designation for its Occular visual cortical prosthesis.